Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS2W
Performance in the last:
Follow this Portfolio
1D 0.8 %
1W 3.7 %
2W 1.7 %
1M 0.8 %
3M 4.8 %
6M -39.2 %
9M -29.9 %
1Y -34.8 %
Alpha
-47.8%
Beta
0.53
sharpe-R
-0.69
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:52
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -49.92%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
NVCR NovoCure Limited Equity Buy 6.86% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 7.29% 6.04%
CERS Cerus Corporation Equity Sell -3.68% 6.64%
The percentage of cash held in the portfolio is: 89.53%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 6.87% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.14% 3.45%
CERS Cerus Corporation Sell -3.87% 2.37%
The percentage of cash held in the portfolio is: 89.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TVTX Travere Therapeutics, Inc. Buy 9.65% 40.42%
NVCR NovoCure Limited Buy 7.13% 2.88%
MYGN Myriad Genetics, Inc. Buy 7.09% 2.3%
CERS Cerus Corporation Sell -3.9% 1.9%
The percentage of cash held in the portfolio is: 80.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All 5.41%
ESPR Sell All 4.37%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 9.47% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -4.92%
TVTX Travere Therapeutics, Inc. Buy 9.01% 27.5%
NVCR NovoCure Limited Buy 6.8% -4.54%
MYGN Myriad Genetics, Inc. Buy 6.94% -2.56%
CERS Cerus Corporation Sell -3.97% 2.84%
The percentage of cash held in the portfolio is: 63.02%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
LMAT Buy All 2.57%
AVXL Buy All 12.76%
PODD Sell All 11.4%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.63% 10.8%
MGNX MacroGenics, Inc. Buy 9.28% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.65% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.42% 33.75%
NVCR NovoCure Limited Buy 6.65% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.11% 0.26%
LMAT LeMaitre Vascular, Inc. Sell -3.69% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.24% 14.88%
VREX Varex Imaging Corporation Sell -3.95% 2.99%
CERS Cerus Corporation Sell -3.96% 2.84%
The percentage of cash held in the portfolio is: 64.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 6.89%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.36% 7.2%
MGNX MacroGenics, Inc. Buy 9.04% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.54% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.48% 33.96%
NVCR NovoCure Limited Buy 6.56% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.17% 0.63%
STAA STAAR Surgical Company Sell -3.6% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.71% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.35% 12.41%
VREX Varex Imaging Corporation Sell -3.58% 12.56%
CERS Cerus Corporation Sell -3.92% 4.27%
The percentage of cash held in the portfolio is: 68.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
SGMO Buy All -22.22%
ALDX Sell All -6.49%
AADI Sell All 3.43%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.65% 4.57%
PODD Insulet Corporation Buy 9.33% 5.05%
MGNX MacroGenics, Inc. Buy 8.66% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.43% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.23% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.42% -3.01%
NVCR NovoCure Limited Buy 6.78% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.25% 0%
STAA STAAR Surgical Company Sell -3.79% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.84% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.4% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.55% -17.04%
BGNE BeiGene, Ltd. Sell -3.28% 0.24%
VREX Varex Imaging Corporation Sell -4.11% 1.28%
CERS Cerus Corporation Sell -3.99% 4.27%
SGMO Sangamo Therapeutics, Inc. Sell -3.04% 0%
The percentage of cash held in the portfolio is: 67.25%
New Assets Added
  • SGMO
  • MYGN
Assets Removed
Asset Action Perf %
CDMO Buy All 16.54%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.51% 2.86%
PODD Insulet Corporation Buy 9.35% 5.72%
MGNX MacroGenics, Inc. Buy 8.96% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.75% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.41% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 7.61% 0%
NVCR NovoCure Limited Buy 7.22% 0%
CDMO Avid Bioservices, Inc. Sell -3.34% 14.93%
STAA STAAR Surgical Company Sell -3.79% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.66% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.01% -3.7%
BGNE BeiGene, Ltd. Sell -3.26% 0.1%
VREX Varex Imaging Corporation Sell -4.24% -2.31%
CERS Cerus Corporation Sell -4.09% 1.42%
The percentage of cash held in the portfolio is: 74.41%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
CARA Sell All -6.41%
AGEN Sell All -8.59%
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 5.62% -6.12%
AGEN Agenus Inc. Buy 5.31% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.49% 2.86%
PODD Insulet Corporation Buy 9.17% 3.96%
MGNX MacroGenics, Inc. Buy 8.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.23% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.48% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 7.59% 0%
CDMO Avid Bioservices, Inc. Sell -3.42% 12.67%
STAA STAAR Surgical Company Sell -3.81% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.69% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.77% 2.22%
BGNE BeiGene, Ltd. Sell -3.21% 1.63%
VREX Varex Imaging Corporation Sell -4.13% 0%
CERS Cerus Corporation Sell -4.13% 0%
The percentage of cash held in the portfolio is: 70.33%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
APLS Sell All -5.21%
ORGO Sell All -4.59%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.79% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.8% -3.5%
AGEN Agenus Inc. Buy 5.43% -9.51%
CERS Cerus Corporation Buy 5.82% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.29% -0.57%
PODD Insulet Corporation Buy 8.94% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.92% -10.38%
MGNX MacroGenics, Inc. Buy 8.7% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.31% 0%
TVTX Travere Therapeutics, Inc. Buy 7.16% 0%
CDMO Avid Bioservices, Inc. Sell -3.62% 8.03%
STAA STAAR Surgical Company Sell -3.92% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.8% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.59% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.84% 0.74%
BGNE BeiGene, Ltd. Sell -3.21% 1.84%
The percentage of cash held in the portfolio is: 44.96%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.92% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.11% 4.96%
AGEN Agenus Inc. Buy 5.48% -5.85%
CERS Cerus Corporation Buy 5.82% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.34% 3.43%
NEOG Neogen Corporation Buy 6.92% 0.35%
PODD Insulet Corporation Buy 8.5% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.47% -1.15%
MGNX MacroGenics, Inc. Buy 9.02% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.02% 0%
CDMO Avid Bioservices, Inc. Sell -3.8% 0.38%
STAA STAAR Surgical Company Sell -3.89% -2.22%
PINC Premier, Inc. Sell -3.92% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% -2.38%
VERU Veru Inc. Sell -3.79% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.8% -1.48%
BGNE BeiGene, Ltd. Sell -3.17% 0%
The percentage of cash held in the portfolio is: 47.08%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.58% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.04% 3.79%
AGEN Agenus Inc. Buy 5.44% -6.58%
CERS Cerus Corporation Buy 5.78% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.89% -4%
NEOG Neogen Corporation Buy 6.75% -2.15%
PODD Insulet Corporation Buy 8.57% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.57% 0%
CDMO Avid Bioservices, Inc. Sell -3.68% 3.4%
STAA STAAR Surgical Company Sell -3.75% 1.42%
PINC Premier, Inc. Sell -3.82% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.75% 0%
AVXL Anavex Life Sciences Corp. Sell -3.75% 0%
VERU Veru Inc. Sell -3.75% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.98% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.02% 4.66%
AGEN Agenus Inc. Buy 5.92% 2.93%
CERS Cerus Corporation Buy 5.91% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.82% -4%
NEOG Neogen Corporation Buy 6.82% 0%
CDMO Avid Bioservices, Inc. Sell -3.66% 2.74%
STAA STAAR Surgical Company Sell -3.76% 0%
PINC Premier, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 63.38%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.09% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.14% 7.87%
AGEN Agenus Inc. Buy 6.11% 7.31%
CERS Cerus Corporation Buy 6% 0%
AADI Aadi Bioscience, Inc. Buy 6% 0%
CDMO Avid Bioservices, Inc. Sell -3.65% 2.08%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.71% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0.64%
ORGO Organogenesis Holdings Inc. Buy 5.93% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.81% 1.46%
AGEN Agenus Inc. Buy 6.07% 6.03%
CDMO Avid Bioservices, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 74.46%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.51% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -1.79%
ORGO Organogenesis Holdings Inc. Buy 5.63% -2.83%
CARA Cara Therapeutics, Inc. Buy 5.8% 0%
AGEN Agenus Inc. Buy 5.8% 0%
The percentage of cash held in the portfolio is: 71.57%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.76% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0%
ORGO Organogenesis Holdings Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 82.71%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-14 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All 22.42%
EGRX Buy All 15.82%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.55% 28.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.06% 13.71%
The percentage of cash held in the portfolio is: 105.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -4.91%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.2% -2.95%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.68% 24.66%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.11% 12.45%
The percentage of cash held in the portfolio is: 99.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPRX Buy All -6.15%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 5.88% -7.66%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.48% 30.04%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.18% 10.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.62% 5.86%
The percentage of cash held in the portfolio is: 103.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Buy All -20.7%
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.17% -1.96%
RMD ResMed Inc. Buy 7.81% 7.5%
INGN Inogen, Inc. Sell -3.25% 6.97%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.67% 23.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.39% 2.95%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.62% 4.47%
The percentage of cash held in the portfolio is: 98.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.38% -1.57%
HQY HealthEquity, Inc. Buy 6.23% -3.84%
SAVA Cassava Sciences, Inc. Buy 10.2% 57.44%
SAGE Sage Therapeutics, Inc. Buy 5.75% -11.19%
HCSG Healthcare Services Group, Inc. Buy 5.93% -3.72%
RMD ResMed Inc. Buy 7.71% 3.13%
INGN Inogen, Inc. Sell -3.57% 0.87%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.26% 9.42%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.63% -0.84%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.83% 1.8%
The percentage of cash held in the portfolio is: 72.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Buy All -1.17%
RARE Buy All -3.2%
NKTR Buy All 5.93%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.7% 3.34%
HQY HealthEquity, Inc. Buy 6.28% -3.09%
SAVA Cassava Sciences, Inc. Buy 9.66% 48.93%
SAGE Sage Therapeutics, Inc. Buy 6.46% -0.36%
HCSG Healthcare Services Group, Inc. Buy 6.09% -1.12%
RMD ResMed Inc. Buy 7.67% 2.5%
PODD Insulet Corporation Sell -3.69% 0.31%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.89% -5.24%
NKTR Nektar Therapeutics Sell -3.67% 0.74%
INGN Inogen, Inc. Sell -3.63% -0.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.64% -0.9%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.66% -1.69%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.91% 0%
The percentage of cash held in the portfolio is: 83.22%
New Assets Added
  • CPRX
Assets Removed
Asset Action Perf %
SMTI Buy All -6.87%
RCM Sell All -1.15%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.5% -1%
CYH Community Health Systems, Inc. Buy 6.72% 1.38%
HQY HealthEquity, Inc. Buy 6.42% -3.16%
SAVA Cassava Sciences, Inc. Buy 7.8% 17.76%
SAGE Sage Therapeutics, Inc. Buy 6.51% -1.73%
HCSG Healthcare Services Group, Inc. Buy 6.27% -0.43%
RMD ResMed Inc. Buy 7.65% 0%
PODD Insulet Corporation Sell -3.75% 0.6%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.95% -4.51%
NKTR Nektar Therapeutics Sell -3.89% -2.96%
SMTI Sanara MedTech Inc. Sell -3.68% 0%
INGN Inogen, Inc. Sell -3.68% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.68% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.68% 0%
The percentage of cash held in the portfolio is: 78.46%
New Assets Added
  • SMTI
  • INGN
  • LXRX
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.32% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 7.2% -4.26%
SMTI Sanara MedTech Inc. Buy 6.19% -5.45%
CYH Community Health Systems, Inc. Buy 6.66% 1.77%
HQY HealthEquity, Inc. Buy 6.44% -1.69%
SAVA Cassava Sciences, Inc. Buy 7.91% 20.78%
SAGE Sage Therapeutics, Inc. Buy 6.44% -1.64%
HCSG Healthcare Services Group, Inc. Buy 6.22% 0%
PODD Insulet Corporation Sell -3.67% 1.61%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.95% -5.75%
NKTR Nektar Therapeutics Sell -3.76% -0.74%
The percentage of cash held in the portfolio is: 58%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
FATE Sell All 39.07%
VERU Sell All -1.22%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 7.27% 39.85%
VERU Veru Inc. Buy 5.19% -0.17%
RCM R1 RCM Inc. Buy 6.46% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 8.21% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 7.62% 1.6%
SMTI Sanara MedTech Inc. Buy 6.53% 0%
CYH Community Health Systems, Inc. Buy 6.53% 0%
HQY HealthEquity, Inc. Buy 6.53% 0%
SAVA Cassava Sciences, Inc. Buy 6.53% 0%
SAGE Sage Therapeutics, Inc. Buy 6.53% 0%
PODD Insulet Corporation Sell -3.69% 0.85%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.91% -4.86%
NKTR Nektar Therapeutics Sell -3.81% -2.22%
RMD ResMed Inc. Sell -3.72% 0%
The percentage of cash held in the portfolio is: 47.72%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
  • SAVA
  • SAGE
Assets Removed
Asset Action Perf %
WAT Buy All -5.03%
MASI Sell All -2.65%
BKD Sell All 8.27%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 1.69% -1.95%
BKD Brookdale Senior Living Inc. Buy 1.82% 5.96%
FATE Fate Therapeutics, Inc. Buy 7.2% 38.82%
VERU Veru Inc. Buy 5.18% -0.17%
RCM R1 RCM Inc. Buy 6.41% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 8.45% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 7.49% 0%
PODD Insulet Corporation Sell -3.64% 2.09%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.92% -5.33%
NKTR Nektar Therapeutics Sell -3.77% -1.48%
WAT Waters Corporation Sell -3.78% -2.5%
The percentage of cash held in the portfolio is: 76.86%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
ANGO Sell All 22.51%
SGRY Sell All 20.35%
AVNS Sell All 8.22%
CUTR Sell All -5.41%
RGNX Sell All 13.22%
SUPN Sell All 7.69%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 7.21% 19.58%
SGRY Surgery Partners, Inc. Buy 7% 16.16%
AVNS Avanos Medical, Inc. Buy 6.43% 6.7%
CUTR Cutera, Inc. Buy 5.86% -2.7%
RGNX REGENXBIO Inc. Buy 6.47% 7.32%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.44% 6.84%
MASI Masimo Corporation Buy 1.7% -2.4%
BKD Brookdale Senior Living Inc. Buy 1.85% 6.23%
FATE Fate Therapeutics, Inc. Buy 6.98% 33.16%
VERU Veru Inc. Buy 5.23% -0.17%
RCM R1 RCM Inc. Buy 6.59% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 8.61% 0%
PODD Insulet Corporation Sell -3.74% 0.3%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.96% -5.45%
NKTR Nektar Therapeutics Sell -3.92% -4.44%
WAT Waters Corporation Sell -3.75% -0.86%
The percentage of cash held in the portfolio is: 45.03%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
PDSB Sell All 6.96%
OPK Sell All 7.58%
SAGE Sell All -11.55%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.25% 9.94%
OPK OPKO Health, Inc. Buy 7.45% 12.88%
ANGO AngioDynamics, Inc. Buy 7.06% 17.13%
SGRY Surgery Partners, Inc. Buy 6.86% 13.7%
AVNS Avanos Medical, Inc. Buy 6.26% 3.82%
CUTR Cutera, Inc. Buy 6.48% 7.43%
RGNX REGENXBIO Inc. Buy 5.97% -1.02%
SAGE Sage Therapeutics, Inc. Buy 6.32% 4.73%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.4% 6.18%
MASI Masimo Corporation Buy 1.66% -4.64%
BKD Brookdale Senior Living Inc. Buy 1.8% 3.66%
FATE Fate Therapeutics, Inc. Buy 5.76% 9.77%
VERU Veru Inc. Buy 4.96% -5.42%
RCM R1 RCM Inc. Buy 6.66% 2%
PODD Insulet Corporation Sell -3.76% -0.04%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.74% 0.54%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
WAT Waters Corporation Sell -3.73% 0%
The percentage of cash held in the portfolio is: 34.19%
New Assets Added
  • WAT
Assets Removed
Asset Action Perf %
TDOC Sell All -2.99%
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.22% 9.66%
ALT Altimmune, Inc. Buy 5.76% -12.43%
OPK OPKO Health, Inc. Buy 7.58% 15.15%
ANGO AngioDynamics, Inc. Buy 6.82% 13.38%
TDOC Teladoc Health, Inc. Buy 5.98% -0.64%
SGRY Surgery Partners, Inc. Buy 6.85% 13.89%
AVNS Avanos Medical, Inc. Buy 6.37% 5.95%
CUTR Cutera, Inc. Buy 6.3% 4.73%
RGNX REGENXBIO Inc. Buy 6.08% 1.1%
SAGE Sage Therapeutics, Inc. Buy 6.24% 3.71%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.15% 2.14%
MASI Masimo Corporation Buy 1.67% -4.06%
BKD Brookdale Senior Living Inc. Buy 1.81% 4.07%
FATE Fate Therapeutics, Inc. Buy 5.8% 10.8%
VERU Veru Inc. Buy 5.17% -1.22%
RCM R1 RCM Inc. Buy 6.42% -1.46%
PODD Insulet Corporation Sell -3.75% 0%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.75% 0%
NKTR Nektar Therapeutics Sell -3.75% 0%
The percentage of cash held in the portfolio is: 19.03%
New Assets Added
  • PODD
  • RARE
  • NKTR
Assets Removed
Asset Action Perf %
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.26% 13.92%
ALT Altimmune, Inc. Buy 6.38% 0.13%
OPK OPKO Health, Inc. Buy 6.86% 7.58%
WST West Pharmaceutical Services, Inc. Buy 5.72% -1.88%
ANGO AngioDynamics, Inc. Buy 7.04% 20.72%
TDOC Teladoc Health, Inc. Buy 6.24% 7.04%
SGRY Surgery Partners, Inc. Buy 6.74% 15.66%
AVNS Avanos Medical, Inc. Buy 6.23% 6.89%
CUTR Cutera, Inc. Buy 6.58% 12.84%
RGNX REGENXBIO Inc. Buy 6.09% 4.48%
SAGE Sage Therapeutics, Inc. Buy 6.03% 3.54%
SUPN Supernus Pharmaceuticals, Inc. Buy 5.92% 1.61%
MASI Masimo Corporation Buy 1.64% -2.67%
BKD Brookdale Senior Living Inc. Buy 1.76% 4.74%
FATE Fate Therapeutics, Inc. Buy 5.81% 14.65%
VERU Veru Inc. Buy 5.38% 6.14%
RCM R1 RCM Inc. Buy 6.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.99% 20.03%
BHVN Biohaven Ltd. Buy 7.07% 6.27%
ALT Altimmune, Inc. Buy 7.03% 5.61%
OPK OPKO Health, Inc. Buy 7.21% 8.33%
WST West Pharmaceutical Services, Inc. Buy 5.84% -3.96%
ANGO AngioDynamics, Inc. Buy 5.88% -3.26%
TDOC Teladoc Health, Inc. Buy 6.01% -1.17%
SGRY Surgery Partners, Inc. Buy 6.13% 0.74%
AVNS Avanos Medical, Inc. Buy 6.01% -1.18%
CUTR Cutera, Inc. Buy 6.33% 4.05%
RGNX REGENXBIO Inc. Buy 6.16% 1.26%
SAGE Sage Therapeutics, Inc. Buy 6.12% 0.55%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.13% 0.84%
MASI Masimo Corporation Buy 1.71% -2.75%
BKD Brookdale Senior Living Inc. Buy 1.8% 2.44%
FATE Fate Therapeutics, Inc. Buy 5.29% 0%
VERU Veru Inc. Buy 5.29% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • FATE
  • VERU
Assets Removed
Asset Action Perf %
APLS Buy All -10.22%
VRDN Sell All 11.2%
RYTM Sell All 21.63%
Assets Rebalanced
None
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.86% 5.15%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.64% 17.23%
PDSB PDS Biotechnology Corporation Buy 7.81% 16.19%
BHVN Biohaven Ltd. Buy 7.08% 5.28%
ALT Altimmune, Inc. Buy 7.1% 5.61%
OPK OPKO Health, Inc. Buy 7.03% 4.55%
WST West Pharmaceutical Services, Inc. Buy 5.96% -3.1%
ANGO AngioDynamics, Inc. Buy 6.02% -2.12%
TDOC Teladoc Health, Inc. Buy 6.16% 0.21%
SGRY Surgery Partners, Inc. Buy 6.47% 5.17%
AVNS Avanos Medical, Inc. Buy 6.12% -0.47%
CUTR Cutera, Inc. Buy 6.11% -0.68%
RGNX REGENXBIO Inc. Buy 6.18% 0.47%
SAGE Sage Therapeutics, Inc. Buy 6.16% 0.21%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.18% 0.46%
MASI Masimo Corporation Buy 1.77% 0%
BKD Brookdale Senior Living Inc. Buy 1.77% 0%
APLS Apellis Pharmaceuticals, Inc. Sell -4.41% -8.93%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MASI
  • BKD
Assets Removed
Asset Action Perf %
SGMO Buy All -25%
CDNA Buy All -10.41%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.49% -1.97%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.23% 9.21%
PDSB PDS Biotechnology Corporation Buy 7.52% 10.23%
BHVN Biohaven Ltd. Buy 7.16% 4.89%
ALT Altimmune, Inc. Buy 7.01% 2.67%
OPK OPKO Health, Inc. Buy 7.08% 3.79%
WST West Pharmaceutical Services, Inc. Buy 6.24% 0%
ANGO AngioDynamics, Inc. Buy 6.24% 0%
TDOC Teladoc Health, Inc. Buy 6.24% 0%
SGRY Surgery Partners, Inc. Buy 6.24% 0%
AVNS Avanos Medical, Inc. Buy 6.24% 0%
CUTR Cutera, Inc. Buy 6.24% 0%
RGNX REGENXBIO Inc. Buy 6.24% 0%
SAGE Sage Therapeutics, Inc. Buy 6.24% 0%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.24% 0%
SGMO Sangamo Therapeutics, Inc. Sell -4.86% -22.22%
APLS Apellis Pharmaceuticals, Inc. Sell -4.41% -7.16%
CDNA CareDx, Inc Sell -3.84% -9.44%
The percentage of cash held in the portfolio is: 14.48%
New Assets Added
  • WST
  • ANGO
  • TDOC
  • SGRY
  • AVNS
  • CUTR
  • RGNX
  • SAGE
  • SUPN
Assets Removed
Asset Action Perf %
FGEN Buy All 4.95%
PAHC Buy All -6.77%
CYH Sell All 15.94%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.12% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 6.24% -7.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.99% 4.01%
PDSB PDS Biotechnology Corporation Buy 6.93% 0%
BHVN Biohaven Ltd. Buy 6.93% 0%
ALT Altimmune, Inc. Buy 6.93% 0%
OPK OPKO Health, Inc. Buy 6.93% 0%
FGEN FibroGen, Inc. Sell -3.41% 12.33%
SGMO Sangamo Therapeutics, Inc. Sell -4.49% -11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.31% -3.17%
PAHC Phibro Animal Health Corporation Sell -3.56% 0%
CDNA CareDx, Inc Sell -3.56% 0%
The percentage of cash held in the portfolio is: 71.27%
New Assets Added
  • PAHC
  • CDNA
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7.01% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 6.22% -6.59%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.01% 5.32%
FGEN FibroGen, Inc. Sell -3.14% 18.54%
SGMO Sangamo Therapeutics, Inc. Sell -3.89% 2.78%
APLS Apellis Pharmaceuticals, Inc. Sell -4.28% -3.44%
The percentage of cash held in the portfolio is: 91.07%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Sell All 6.02%
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 6.46% 4.12%
CYH Community Health Systems, Inc. Buy 6.8% 1.25%
NVRO Nevro Corp. Buy 6.43% -2.79%
VRDN Viridian Therapeutics, Inc. Buy 6.17% -6.81%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.79% 2.55%
FGEN FibroGen, Inc. Sell -3.01% 21.46%
SGMO Sangamo Therapeutics, Inc. Sell -3.54% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.19% -1.98%
The percentage of cash held in the portfolio is: 78.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Sell All -3.41%
ACAD Sell All 2.77%
EGRX Sell All 34.15%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.82% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.28% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 0.9%
CYH Community Health Systems, Inc. Buy 7.09% 5.31%
NVRO Nevro Corp. Buy 6.46% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 6.15% -7.27%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.35% -4.36%
VERU Veru Inc. Buy 6.86% 3.41%
FGEN FibroGen, Inc. Sell -2.58% 32.91%
SGMO Sangamo Therapeutics, Inc. Sell -3.55% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.02% 2.42%
The percentage of cash held in the portfolio is: 57.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.88% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.88% 16.74%
STAA STAAR Surgical Company Buy 6.51% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.36% 2.79%
CYH Community Health Systems, Inc. Buy 7.18% 7.19%
NVRO Nevro Corp. Buy 6.4% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 6.08% -7.95%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.55% -0.77%
VERU Veru Inc. Buy 7.13% 7.95%
FGEN FibroGen, Inc. Sell -2.76% 27.86%
SGMO Sangamo Therapeutics, Inc. Sell -3.53% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 3.61%
The percentage of cash held in the portfolio is: 51.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.74% 1.01%
MNKD MannKind Corporation Buy 5.33% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.02% 23.44%
STAA STAAR Surgical Company Buy 6.69% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.16% 3.19%
CYH Community Health Systems, Inc. Buy 6.7% 3.75%
ARDX Ardelyx, Inc. Buy 6.95% 2.16%
CHRS Coherus BioSciences, Inc. Buy 6.33% -6.94%
NVRO Nevro Corp. Buy 6.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 6.37% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.37% 0%
VERU Veru Inc. Buy 6.37% 0%
FGEN FibroGen, Inc. Sell -2.75% 25.24%
SGMO Sangamo Therapeutics, Inc. Sell -3.51% 8.33%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 0%
The percentage of cash held in the portfolio is: 33.83%
New Assets Added
  • APLS
  • NVRO
  • VRDN
  • RYTM
  • VERU
Assets Removed
Asset Action Perf %
NVRO Buy All -8.17%
MODV Buy All -8.11%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.81% 2.33%
MNKD MannKind Corporation Buy 5.46% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.09% 25%
STAA STAAR Surgical Company Buy 6.7% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.15% 3.14%
CYH Community Health Systems, Inc. Buy 6.77% 5%
ARDX Ardelyx, Inc. Buy 6.79% 0%
CHRS Coherus BioSciences, Inc. Buy 6.79% 0%
NVRO Nevro Corp. Sell -3.89% -5.78%
MODV ModivCare Inc. Sell -3.82% -4.83%
FGEN FibroGen, Inc. Sell -3.18% 13.4%
SGMO Sangamo Therapeutics, Inc. Sell -3.82% 0%
The percentage of cash held in the portfolio is: 63.15%
New Assets Added
  • SGMO
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.93% 3.09%
MNKD MannKind Corporation Buy 5.6% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.44% 12.05%
STAA STAAR Surgical Company Buy 6.67% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 3.94%
CYH Community Health Systems, Inc. Buy 6.54% 0%
NVRO Nevro Corp. Sell -3.92% -5.03%
MODV ModivCare Inc. Sell -3.73% -0.84%
FGEN FibroGen, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 73.9%
New Assets Added
  • FGEN
  • CYH
Assets Removed
Asset Action Perf %
AVXL Buy All -12.3%
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.64% -2.39%
MNKD MannKind Corporation Buy 5.52% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.35% 9.82%
STAA STAAR Surgical Company Buy 6.52% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.17% 1.71%
NVRO Nevro Corp. Sell -4.01% -7.16%
MODV ModivCare Inc. Sell -3.71% 0%
AVXL Anavex Life Sciences Corp. Sell -3.71% 0%
The percentage of cash held in the portfolio is: 81.24%
New Assets Added
  • MODV
  • AVXL
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.68% -1.76%
MNKD MannKind Corporation Buy 5.58% -3.5%
FGEN FibroGen, Inc. Buy 5.64% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.88% 1.56%
STAA STAAR Surgical Company Buy 6.07% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.07% 0%
NVRO Nevro Corp. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 68.82%
New Assets Added
  • NVRO
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.76% 0%
MNKD MannKind Corporation Buy 5.76% 0%
FGEN FibroGen, Inc. Buy 5.76% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 76.94%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SLP Buy All 5.86%
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
SLP Simulations Plus, Inc. Sell -4.63% 9.52%
The percentage of cash held in the portfolio is: 104.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All 7.35%
Assets Rebalanced
None
2024-06-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
BGNE BeiGene, Ltd. Sell -2.98% 12.64%
SLP Simulations Plus, Inc. Sell -4.7% 7.98%
The percentage of cash held in the portfolio is: 107.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
GERN Buy All -9.74%
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
BGNE BeiGene, Ltd. Sell -3.03% 11.08%
SLP Simulations Plus, Inc. Sell -4.93% 3.48%
GERN Geron Corporation Sell -4.35% -1.72%
The percentage of cash held in the portfolio is: 112.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Buy All -2.26%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ICUI ICU Medical, Inc. Sell -4.07% 2.74%
BGNE BeiGene, Ltd. Sell -3.07% 9.62%
SLP Simulations Plus, Inc. Sell -4.94% 2.88%
GERN Geron Corporation Sell -4.05% 4.87%
The percentage of cash held in the portfolio is: 116.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Buy All -12.87%
SGMO Sell All -12.31%
RCM Sell All 3.04%
BCRX Sell All -3.3%
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.37% 2%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.07% -2.67%
SGMO Sangamo Therapeutics, Inc. Buy 8.58% -4.62%
ICUI ICU Medical, Inc. Sell -4.2% -0.88%
TVTX Travere Therapeutics, Inc. Sell -4.65% -11.55%
BGNE BeiGene, Ltd. Sell -3.1% 8.53%
SLP Simulations Plus, Inc. Sell -5.04% 0.46%
GERN Geron Corporation Sell -4.07% 4.01%
The percentage of cash held in the portfolio is: 100.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 10.3%
VKTX Buy All 5.36%
BLFS Sell All -1.34%
Assets Rebalanced
None
2024-05-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 7.47% -3.17%
RCM R1 RCM Inc. Buy 6.23% -0.16%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.01% -3.62%
SGMO Sangamo Therapeutics, Inc. Buy 8.29% -7.69%
VKTX Viking Therapeutics, Inc. Sell -3.54% 9.14%
ICUI ICU Medical, Inc. Sell -4.07% 2.22%
TVTX Travere Therapeutics, Inc. Sell -4.23% -1.65%
BGNE BeiGene, Ltd. Sell -3.09% 8.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -2.89% 14.42%
SLP Simulations Plus, Inc. Sell -5.05% 0.3%
GERN Geron Corporation Sell -4.23% 0.29%
The percentage of cash held in the portfolio is: 99.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Sell All NA
EDIT Sell All NA
PACB Sell All NA
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 7.45% 0.25%
EDIT Editas Medicine, Inc. Buy 7.33% -1.4%
PACB Pacific Biosciences of California, Inc. Buy 7.2% -3.11%
BLFS BioLife Solutions, Inc. Buy 7.47% -3.17%
RCM R1 RCM Inc. Buy 6.23% -0.16%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.01% -3.62%
SGMO Sangamo Therapeutics, Inc. Buy 8.29% -7.69%
VKTX Viking Therapeutics, Inc. Sell -3.54% 9.14%
ICUI ICU Medical, Inc. Sell -4.07% 2.22%
TVTX Travere Therapeutics, Inc. Sell -4.23% -1.65%
BGNE BeiGene, Ltd. Sell -3.09% 8.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -2.89% 14.42%
SLP Simulations Plus, Inc. Sell -5.05% 0.3%
GERN Geron Corporation Sell -4.23% 0.29%
The percentage of cash held in the portfolio is: 77.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGRY Buy All 4.51%
CARA Sell All -16.65%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 7.66% 4.51%
EDIT Editas Medicine, Inc. Buy 7.48% 2.1%
PACB Pacific Biosciences of California, Inc. Buy 7.37% 0.52%
BLFS BioLife Solutions, Inc. Buy 7.15% -5.97%
RCM R1 RCM Inc. Buy 5.97% -2.92%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.12% -0.47%
CARA Cara Therapeutics, Inc. Buy 6.53% -8.82%
SGMO Sangamo Therapeutics, Inc. Buy 8.45% -4.62%
SGRY Surgery Partners, Inc. Sell -3.05% 8.09%
VKTX Viking Therapeutics, Inc. Sell -3.43% 10.85%
ICUI ICU Medical, Inc. Sell -4.12% -0.29%
TVTX Travere Therapeutics, Inc. Sell -4.3% -4.62%
BGNE BeiGene, Ltd. Sell -3.11% 6.7%
EGRX Eagle Pharmaceuticals, Inc. Sell -2.85% 14.65%
SLP Simulations Plus, Inc. Sell -4.96% 0.62%
GERN Geron Corporation Sell -4.18% 0%
The percentage of cash held in the portfolio is: 73.27%
New Assets Added
  • GERN
Assets Removed
Asset Action Perf %
VRDN Buy All 12.58%
GERN Sell All -10.51%
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 6.95% -3.91%
AVXL Anavex Life Sciences Corp. Buy 8.15% 12.78%
EDIT Editas Medicine, Inc. Buy 7.62% 5.43%
PACB Pacific Biosciences of California, Inc. Buy 6.93% -4.15%
BLFS BioLife Solutions, Inc. Buy 7.32% -2.45%
RCM R1 RCM Inc. Buy 5.9% -2.72%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.36% 4.72%
GERN Geron Corporation Buy 5.7% -6.15%
CARA Cara Therapeutics, Inc. Buy 6.76% -4.35%
SGMO Sangamo Therapeutics, Inc. Buy 8.61% -1.54%
VRDN Viridian Therapeutics, Inc. Sell -3.83% 8.7%
SGRY Surgery Partners, Inc. Sell -3.11% 5.27%
VKTX Viking Therapeutics, Inc. Sell -3.46% 8.76%
ICUI ICU Medical, Inc. Sell -4.11% -1.55%
TVTX Travere Therapeutics, Inc. Sell -4.39% -8.25%
BGNE BeiGene, Ltd. Sell -3.3% -0.32%
EGRX Eagle Pharmaceuticals, Inc. Sell -2.87% 12.81%
SLP Simulations Plus, Inc. Sell -4.93% 0%
The percentage of cash held in the portfolio is: 59.71%
New Assets Added
  • SLP
Assets Removed
Asset Action Perf %
BKD Buy All 3.14%
PODD Sell All -2.32%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 7.16% -3.2%
AVXL Anavex Life Sciences Corp. Buy 8.07% 9.02%
EDIT Editas Medicine, Inc. Buy 7.14% -3.5%
PACB Pacific Biosciences of California, Inc. Buy 7.01% -5.18%
BLFS BioLife Solutions, Inc. Buy 7.42% -3.34%
RCM R1 RCM Inc. Buy 6.1% -1.76%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.27% 0.94%
GERN Geron Corporation Buy 5.89% -5.13%
PODD Insulet Corporation Buy 7.13% -1.4%
CARA Cara Therapeutics, Inc. Buy 6.77% -6.34%
SGMO Sangamo Therapeutics, Inc. Buy 8.26% -7.69%
BKD Brookdale Senior Living Inc. Sell -3.85% 1.57%
VRDN Viridian Therapeutics, Inc. Sell -3.98% 7.4%
SGRY Surgery Partners, Inc. Sell -3.21% 4.48%
VKTX Viking Therapeutics, Inc. Sell -3.61% 6.99%
ICUI ICU Medical, Inc. Sell -4.1% 1.2%
TVTX Travere Therapeutics, Inc. Sell -4.52% -9.08%
BGNE BeiGene, Ltd. Sell -3.37% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.37% 0%
The percentage of cash held in the portfolio is: 52.78%
New Assets Added
  • BGNE
  • EGRX
Assets Removed
Asset Action Perf %
MDRX Buy All -2.53%
ILMN Buy All 4.62%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 7.3% -0.89%
AVXL Anavex Life Sciences Corp. Buy 8.17% 11.03%
EDIT Editas Medicine, Inc. Buy 7.12% -3.33%
PACB Pacific Biosciences of California, Inc. Buy 7.32% -0.52%
BLFS BioLife Solutions, Inc. Buy 7.44% -2.67%
RCM R1 RCM Inc. Buy 6.05% -2.08%
BCRX BioCryst Pharmaceuticals, Inc. Buy 5.96% -3.62%
GERN Geron Corporation Buy 5.91% -4.36%
PODD Insulet Corporation Buy 7.15% -0.67%
CARA Cara Therapeutics, Inc. Buy 6.7% -6.83%
SGMO Sangamo Therapeutics, Inc. Buy 8.36% -6.15%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.92% -3.2%
ILMN Illumina, Inc. Sell -3.65% 3.8%
BKD Brookdale Senior Living Inc. Sell -3.82% 2%
VRDN Viridian Therapeutics, Inc. Sell -4.16% 2.73%
SGRY Surgery Partners, Inc. Sell -3.2% 4.21%
VKTX Viking Therapeutics, Inc. Sell -3.78% 2.24%
ICUI ICU Medical, Inc. Sell -4.1% 0.72%
TVTX Travere Therapeutics, Inc. Sell -4.2% -1.82%
The percentage of cash held in the portfolio is: 53.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -5.82%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 7.3% 1.69%
AVXL Anavex Life Sciences Corp. Buy 8.18% 14.04%
EDIT Editas Medicine, Inc. Buy 7.06% -1.58%
PACB Pacific Biosciences of California, Inc. Buy 7.51% 4.66%
BLFS BioLife Solutions, Inc. Buy 7.29% -2.1%
RCM R1 RCM Inc. Buy 5.99% -0.56%
BCRX BioCryst Pharmaceuticals, Inc. Buy 5.95% -1.26%
GERN Geron Corporation Buy 5.88% -2.31%
PODD Insulet Corporation Buy 7.08% 1.02%
NVRO Nevro Corp. Buy 7.15% 2.06%
CARA Cara Therapeutics, Inc. Buy 6.53% -6.83%
SGMO Sangamo Therapeutics, Inc. Buy 8.68% 0%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.72% -0.53%
ILMN Illumina, Inc. Sell -3.64% 1.55%
BKD Brookdale Senior Living Inc. Sell -3.75% 1.29%
VRDN Viridian Therapeutics, Inc. Sell -4.03% 3.31%
SGRY Surgery Partners, Inc. Sell -3.16% 2.86%
VKTX Viking Therapeutics, Inc. Sell -3.65% 2.98%
ICUI ICU Medical, Inc. Sell -4.02% 0%
TVTX Travere Therapeutics, Inc. Sell -4.02% 0%
The percentage of cash held in the portfolio is: 45.39%
New Assets Added
  • ICUI
  • TVTX
  • SGMO
Assets Removed
Asset Action Perf %
NUTX Sell All 4.74%
AORT Sell All 12.09%
OMCL Sell All 1.03%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 8.29% 8.41%
AORT Artivion, Inc. Buy 7.68% 12.28%
OMCL Omnicell, Inc. Buy 7.28% 5.08%
VCYT Veracyte, Inc. Buy 7.37% 4%
AVXL Anavex Life Sciences Corp. Buy 7.99% 12.78%
EDIT Editas Medicine, Inc. Buy 7.31% 3.15%
PACB Pacific Biosciences of California, Inc. Buy 8.04% 13.47%
BLFS BioLife Solutions, Inc. Buy 7.2% -2.05%
RCM R1 RCM Inc. Buy 5.86% -1.52%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.05% 1.73%
GERN Geron Corporation Buy 5.95% 0%
PODD Insulet Corporation Buy 6.92% 0%
NVRO Nevro Corp. Buy 6.92% 0%
CARA Cara Therapeutics, Inc. Buy 6.92% 0%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.82% -4.53%
ILMN Illumina, Inc. Sell -3.71% -1.45%
BKD Brookdale Senior Living Inc. Sell -3.78% -1%
VRDN Viridian Therapeutics, Inc. Sell -4.33% -5.18%
SGRY Surgery Partners, Inc. Sell -3.2% 0.53%
VKTX Viking Therapeutics, Inc. Sell -3.72% 0%
The percentage of cash held in the portfolio is: 22.77%
New Assets Added
  • VKTX
  • PODD
  • NVRO
  • CARA
Assets Removed
Asset Action Perf %
BGNE Buy All -5.46%
ALT Sell All 23.78%
GKOS Sell All 5.12%
KIDS Sell All -0.06%
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALT Altimmune, Inc. Buy 9.02% 23.37%
GKOS Glaukos Corporation Buy 7.28% 6.06%
KIDS OrthoPediatrics Corp. Buy 6.79% -1.38%
NUTX Nutex Health Inc. Buy 8.05% 5.62%
AORT Artivion, Inc. Buy 7.73% 13.38%
OMCL Omnicell, Inc. Buy 6.84% -0.86%
MD Pediatrix Medical Group, Inc. Buy 6.79% -3.87%
VCYT Veracyte, Inc. Buy 7.39% 4.67%
AVXL Anavex Life Sciences Corp. Buy 7.94% 12.53%
EDIT Editas Medicine, Inc. Buy 7.42% 5.08%
PACB Pacific Biosciences of California, Inc. Buy 7.86% 11.4%
BLFS BioLife Solutions, Inc. Buy 7.51% 2.5%
RCM R1 RCM Inc. Buy 5.93% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 5.93% 0%
GERN Geron Corporation Buy 5.93% 0%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.64% 0.13%
ILMN Illumina, Inc. Sell -3.71% -1.94%
BKD Brookdale Senior Living Inc. Sell -3.8% -1.71%
VRDN Viridian Therapeutics, Inc. Sell -4.21% -2.59%
SGRY Surgery Partners, Inc. Sell -3.26% -1.81%
BGNE BeiGene, Ltd. Sell -3.63% -1.67%
The percentage of cash held in the portfolio is: 13.85%
New Assets Added
  • RCM
  • BCRX
  • GERN
Assets Removed
Asset Action Perf %
FOLD Buy All -4.66%
ARWR Buy All -13.51%
INGN Sell All 25.39%
SGMO Sell All 7.41%
RYTM Sell All -4.42%
ACRS Sell All -6.35%
WST Sell All -4.6%
Assets Rebalanced
None
2024-05-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 9.3% 26.52%
SGMO Sangamo Therapeutics, Inc. Buy 7.76% 5.56%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.54% -2.53%
ACRS Aclaris Therapeutics, Inc. Buy 5.64% -6.35%
ALT Altimmune, Inc. Buy 8.04% 8.76%
GKOS Glaukos Corporation Buy 7.34% 5.66%
WST West Pharmaceutical Services, Inc. Buy 7.42% -3.79%
KIDS OrthoPediatrics Corp. Buy 6.86% -1.54%
NUTX Nutex Health Inc. Buy 8.05% 4.44%
AORT Artivion, Inc. Buy 7.73% 11.99%
OMCL Omnicell, Inc. Buy 7.01% 0.5%
MD Pediatrix Medical Group, Inc. Buy 7.1% -0.59%
VCYT Veracyte, Inc. Buy 7.31% 2.31%
AVXL Anavex Life Sciences Corp. Buy 7.72% 8.02%
EDIT Editas Medicine, Inc. Buy 7.11% -0.53%
PACB Pacific Biosciences of California, Inc. Buy 8.25% 15.54%
BLFS BioLife Solutions, Inc. Buy 7.42% 0%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.68% 0.13%
ILMN Illumina, Inc. Sell -3.78% -2.45%
BKD Brookdale Senior Living Inc. Sell -3.86% -2.14%
VRDN Viridian Therapeutics, Inc. Sell -4.38% -5.46%
SGRY Surgery Partners, Inc. Sell -3.29% -1.39%
FOLD Amicus Therapeutics, Inc. Sell -3.28% -1.08%
BGNE BeiGene, Ltd. Sell -3.59% 0.86%
ARWR Arrowhead Pharmaceuticals, Inc. Sell -3.76% -3.85%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BLFS
Assets Removed
Asset Action Perf %
SENS Sell All 0.62%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
SENS Senseonics Holdings, Inc. Buy 6.99% -8.83%
INGN Inogen, Inc. Buy 9.49% 25.04%
SGMO Sangamo Therapeutics, Inc. Buy 7.73% 1.85%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.74% -2.97%
ACRS Aclaris Therapeutics, Inc. Buy 5.81% -6.35%
ALT Altimmune, Inc. Buy 7.82% 2.5%
GKOS Glaukos Corporation Buy 7.39% 3.17%
WST West Pharmaceutical Services, Inc. Buy 7.73% -2.79%
KIDS OrthoPediatrics Corp. Buy 7.03% -2.14%
NUTX Nutex Health Inc. Buy 8.18% 2.82%
AORT Artivion, Inc. Buy 7.89% 10.85%
OMCL Omnicell, Inc. Buy 7.36% 2.22%
MD Pediatrix Medical Group, Inc. Buy 7.37% 0%
VCYT Veracyte, Inc. Buy 7.37% 0%
AVXL Anavex Life Sciences Corp. Buy 7.37% 0%
EDIT Editas Medicine, Inc. Buy 7.37% 0%
PACB Pacific Biosciences of California, Inc. Buy 7.37% 0%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.91% -2.8%
ILMN Illumina, Inc. Sell -3.8% 0.04%
BKD Brookdale Senior Living Inc. Sell -3.89% 0.14%
VRDN Viridian Therapeutics, Inc. Sell -4.41% -3.09%
SGRY Surgery Partners, Inc. Sell -3.25% 2.67%
FOLD Amicus Therapeutics, Inc. Sell -3.27% 2.06%
BGNE BeiGene, Ltd. Sell -3.73% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BGNE
  • ARWR
  • MD
  • VCYT
  • AVXL
  • EDIT
  • PACB
Assets Removed
Asset Action Perf %
MD Buy All -0.35%
ALGN Buy All 10.52%
IBRX Sell All -4%
CARA Sell All -0.79%
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 7.57% -9.68%
CARA Cara Therapeutics, Inc. Buy 6.93% -5.29%
SENS Senseonics Holdings, Inc. Buy 7.45% -4.31%
INGN Inogen, Inc. Buy 9.25% 20%
SGMO Sangamo Therapeutics, Inc. Buy 7.99% 3.7%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.65% -5.53%
ACRS Aclaris Therapeutics, Inc. Buy 5.85% -7.14%
ALT Altimmune, Inc. Buy 7.78% 0.42%
GKOS Glaukos Corporation Buy 7.66% 5.17%
WST West Pharmaceutical Services, Inc. Buy 7.99% -1.16%
KIDS OrthoPediatrics Corp. Buy 7.13% -2.26%
NUTX Nutex Health Inc. Buy 7.5% -7.18%
AORT Artivion, Inc. Buy 8.13% 12.42%
OMCL Omnicell, Inc. Buy 7.31% -0.03%
ALGN Align Technology, Inc. Sell -3.26% 10.87%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.01% -3.73%
ILMN Illumina, Inc. Sell -3.78% 2.03%
MD Pediatrix Medical Group, Inc. Sell -3.83% 3.29%
BKD Brookdale Senior Living Inc. Sell -3.99% -0.86%
VRDN Viridian Therapeutics, Inc. Sell -4.34% 0.07%
SGRY Surgery Partners, Inc. Sell -3.39% 0%
FOLD Amicus Therapeutics, Inc. Sell -3.39% 0%
The percentage of cash held in the portfolio is: 23.82%
New Assets Added
  • SGRY
  • FOLD
Assets Removed
Asset Action Perf %
NVRO Buy All 13.52%
ITGR Buy All -4.01%
PTCT Sell All 12.88%
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.09% 8.68%
IBRX ImmunityBio, Inc. Buy 7.33% -10.34%
CARA Cara Therapeutics, Inc. Buy 7.18% 0.53%
SENS Senseonics Holdings, Inc. Buy 7.5% -1.23%
INGN Inogen, Inc. Buy 9.27% 23.26%
SGMO Sangamo Therapeutics, Inc. Buy 7.24% -3.7%
IOVA Iovance Biotherapeutics, Inc. Buy 7.93% 7.6%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.35% -7.07%
ACRS Aclaris Therapeutics, Inc. Buy 5.98% -2.78%
ALT Altimmune, Inc. Buy 8.12% 7.37%
GKOS Glaukos Corporation Buy 7.28% 2.47%
WST West Pharmaceutical Services, Inc. Buy 7.82% -0.78%
KIDS OrthoPediatrics Corp. Buy 7.5% 5.28%
NUTX Nutex Health Inc. Buy 7.66% -2.91%
AORT Artivion, Inc. Buy 7.89% 11.8%
OMCL Omnicell, Inc. Buy 7.17% 0.4%
NVRO Nevro Corp. Sell -3.39% 7.16%
ITGR Integer Holdings Corporation Sell -3.81% -4.24%
ALGN Align Technology, Inc. Sell -3.28% 8.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.89% -3.2%
ILMN Illumina, Inc. Sell -3.72% 1.3%
MD Pediatrix Medical Group, Inc. Sell -3.71% 3.88%
BKD Brookdale Senior Living Inc. Sell -3.96% -2.43%
VRDN Viridian Therapeutics, Inc. Sell -4.24% 0%
The percentage of cash held in the portfolio is: 8.71%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
ACHC Buy All -6.61%
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.23% 9%
IBRX ImmunityBio, Inc. Buy 7.3% -11.9%
CDMO Avid Bioservices, Inc. Buy 7.17% 10.85%
CARA Cara Therapeutics, Inc. Buy 7.02% -3.04%
SENS Senseonics Holdings, Inc. Buy 7.53% -2.26%
INGN Inogen, Inc. Buy 8.91% 16.88%
SGMO Sangamo Therapeutics, Inc. Buy 7.06% -7.41%
IOVA Iovance Biotherapeutics, Inc. Buy 8% 7.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.53% -6.06%
ACRS Aclaris Therapeutics, Inc. Buy 6.04% -3.17%
ALT Altimmune, Inc. Buy 7.63% -0.42%
GKOS Glaukos Corporation Buy 7.33% 1.79%
WST West Pharmaceutical Services, Inc. Buy 7.96% -0.49%
KIDS OrthoPediatrics Corp. Buy 7.53% 4.31%
NUTX Nutex Health Inc. Buy 7.61% -4.82%
AORT Artivion, Inc. Buy 7.96% 11.32%
OMCL Omnicell, Inc. Buy 7.2% -0.56%
NVRO Nevro Corp. Sell -3.32% 10.25%
ITGR Integer Holdings Corporation Sell -3.82% -3.25%
ALGN Align Technology, Inc. Sell -3.25% 10.23%
ACHC Acadia Healthcare Company, Inc. Sell -4.16% 0.09%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.87% -1.33%
ILMN Illumina, Inc. Sell -3.75% 1.95%
MD Pediatrix Medical Group, Inc. Sell -3.92% 0%
BKD Brookdale Senior Living Inc. Sell -3.92% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • BKD
Assets Removed
None
Assets Rebalanced
Asset Action Weight
WST Buy 0.33%
PTCT Buy 0.37%
IOVA Buy 0.58%
KIDS Buy 1.06%
RYTM Buy 1.14%
SENS Buy 1.27%
CARA Buy 0.95%
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.18% 11.27%
IBRX ImmunityBio, Inc. Buy 7.49% -8.12%
CDMO Avid Bioservices, Inc. Buy 7.36% 15.87%
CARA Cara Therapeutics, Inc. Buy 6.45% 4.76%
SENS Senseonics Holdings, Inc. Buy 6.47% 2.87%
SGMO Sangamo Therapeutics, Inc. Buy 7.49% 0%
INGN Inogen, Inc. Buy 7.76% 3.55%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.35% -5.02%
IOVA Iovance Biotherapeutics, Inc. Buy 7.13% 11.84%
ACRS Aclaris Therapeutics, Inc. Buy 6.52% 6.35%
KIDS OrthoPediatrics Corp. Buy 6.65% 9.09%
ALT Altimmune, Inc. Buy 7.62% 1.11%
GKOS Glaukos Corporation Buy 7.28% 2.81%
WST West Pharmaceutical Services, Inc. Buy 7.11% -0.03%
NUTX Nutex Health Inc. Buy 7.04% -10.41%
OMCL Omnicell, Inc. Buy 7.15% 0.56%
AORT Artivion, Inc. Buy 7.98% 13.57%
ITGR Integer Holdings Corporation Sell -3.76% -3.25%
NVRO Nevro Corp. Sell -3.71% -1.86%
ALGN Align Technology, Inc. Sell -3.34% 6%
ACHC Acadia Healthcare Company, Inc. Sell -4.17% -1.98%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.76% 0%
ILMN Illumina, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 1.44%
New Assets Added
  • MDRX
  • ILMN
Assets Removed
Asset Action Perf %
OFIX Buy All -6.93%
EGRX Buy All -17.28%
Assets Rebalanced
None
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.47% 15.37%
IBRX ImmunityBio, Inc. Buy 7.1% -13.13%
CDMO Avid Bioservices, Inc. Buy 7.1% 11.38%
CARA Cara Therapeutics, Inc. Buy 6.45% 4.5%
SENS Senseonics Holdings, Inc. Buy 6.53% 3.49%
SGMO Sangamo Therapeutics, Inc. Buy 7.38% -1.85%
INGN Inogen, Inc. Buy 7.67% 1.99%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.1% 5.91%
IOVA Iovance Biotherapeutics, Inc. Buy 7.1% 11.04%
ACRS Aclaris Therapeutics, Inc. Buy 6.39% 3.97%
KIDS OrthoPediatrics Corp. Buy 6.46% 5.63%
ALT Altimmune, Inc. Buy 7.74% 2.36%
GKOS Glaukos Corporation Buy 7.1% -0.02%
WST West Pharmaceutical Services, Inc. Buy 7.1% -0.52%
NUTX Nutex Health Inc. Buy 7.8% -1%
OMCL Omnicell, Inc. Buy 7.1% -0.5%
AORT Artivion, Inc. Buy 7.1% 0.67%
OFIX Orthofix Medical Inc. Sell -3.78% -3.62%
ITGR Integer Holdings Corporation Sell -3.72% -1.96%
NVRO Nevro Corp. Sell -3.6% 1.5%
ALGN Align Technology, Inc. Sell -3.36% 5.72%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.02% -12.84%
ACHC Acadia Healthcare Company, Inc. Sell -4.2% -2.51%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Buy All -10.12%
Assets Rebalanced
Asset Action Weight
CARA Sell -1.06%
SENS Sell -1.25%
ACRS Sell -1.42%
OMCL Sell -0.74%
AORT Sell -0.84%
RYTM Sell -0.86%
CDMO Sell -0.9%
IOVA Sell -1.25%
ALT Buy 0.84%
IBRX Buy 0.86%
GKOS Buy 0.98%
WST Buy 1.01%
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.36% 15.54%
IBRX ImmunityBio, Inc. Buy 7.2% 1.78%
CDMO Avid Bioservices, Inc. Buy 7.72% 9.13%
CARA Cara Therapeutics, Inc. Buy 7.28% 2.94%
SENS Senseonics Holdings, Inc. Buy 7.68% 3.68%
INGN Inogen, Inc. Buy 7.51% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 7.99% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 8.07% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 7.62% 2.93%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.82% 5.62%
GKOS Glaukos Corporation Buy 6.11% 1.41%
WST West Pharmaceutical Services, Inc. Buy 5.97% -0.93%
KIDS OrthoPediatrics Corp. Buy 6.22% 3.21%
ALT Altimmune, Inc. Buy 6.12% 1.53%
OMCL Omnicell, Inc. Buy 7.76% 0%
NUTX Nutex Health Inc. Buy 7.76% 0%
AORT Artivion, Inc. Buy 7.76% 0%
ATRI Atrion Corporation Sell -3.78% -5.05%
NVRO Nevro Corp. Sell -3.59% 0.27%
ITGR Integer Holdings Corporation Sell -3.65% -1.54%
OFIX Orthofix Medical Inc. Sell -3.76% -4.7%
ALGN Align Technology, Inc. Sell -3.32% 5.56%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.82% -8.89%
ACHC Acadia Healthcare Company, Inc. Sell -4.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ACHC
  • OMCL
  • NUTX
  • AORT
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.69% 17.68%
SMMT Summit Therapeutics Inc. Buy 6.87% 5.18%
IBRX ImmunityBio, Inc. Buy 7.23% -0.22%
CDMO Avid Bioservices, Inc. Buy 7.86% 8.47%
CARA Cara Therapeutics, Inc. Buy 7.4% 2.12%
SENS Senseonics Holdings, Inc. Buy 8.07% 6.37%
INGN Inogen, Inc. Buy 7.56% -0.28%
ACRS Aclaris Therapeutics, Inc. Buy 7.89% 3.97%
IOVA Iovance Biotherapeutics, Inc. Buy 7.82% 3.04%
SGMO Sangamo Therapeutics, Inc. Buy 7.3% -3.7%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.5% -1.09%
GKOS Glaukos Corporation Buy 6.17% 0%
WST West Pharmaceutical Services, Inc. Buy 6.17% 0%
KIDS OrthoPediatrics Corp. Buy 6.17% 0%
ALT Altimmune, Inc. Buy 6.17% 0%
ATRI Atrion Corporation Sell -3.87% -5.05%
NVRO Nevro Corp. Sell -3.63% 1.5%
ITGR Integer Holdings Corporation Sell -3.7% -0.31%
OFIX Orthofix Medical Inc. Sell -3.76% -1.92%
ALGN Align Technology, Inc. Sell -3.38% 6%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.91% -8.64%
The percentage of cash held in the portfolio is: 14.35%
New Assets Added
  • GKOS
  • WST
  • KIDS
  • ALT
Assets Removed
Asset Action Perf %
ALT Buy All -12.43%
GKOS Buy All -9.41%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.81% 19.57%
SMMT Summit Therapeutics Inc. Buy 7.96% 21.76%
IBRX ImmunityBio, Inc. Buy 6.89% -5.01%
CDMO Avid Bioservices, Inc. Buy 7.36% 1.46%
CARA Cara Therapeutics, Inc. Buy 7.28% 0.4%
SENS Senseonics Holdings, Inc. Buy 7.22% -4.93%
INGN Inogen, Inc. Buy 7.59% 0%
ACRS Aclaris Therapeutics, Inc. Buy 7.59% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 7.59% 0%
SGMO Sangamo Therapeutics, Inc. Buy 7.59% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.59% 0%
ATRI Atrion Corporation Sell -3.98% -8.07%
NVRO Nevro Corp. Sell -3.39% 8.04%
ITGR Integer Holdings Corporation Sell -3.69% -0.18%
OFIX Orthofix Medical Inc. Sell -3.7% -0.31%
ALGN Align Technology, Inc. Sell -3.36% 6.66%
ALT Altimmune, Inc. Sell -3.98% -10.56%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.72% -3.46%
GKOS Glaukos Corporation Sell -4.18% -3.03%
The percentage of cash held in the portfolio is: 47.54%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
  • RYTM
Assets Removed
None
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.46% 12.53%
SMMT Summit Therapeutics Inc. Buy 6.75% 1.81%
IBRX ImmunityBio, Inc. Buy 6.54% -11.12%
CDMO Avid Bioservices, Inc. Buy 7.43% 0.93%
CARA Cara Therapeutics, Inc. Buy 7.32% -0.53%
SENS Senseonics Holdings, Inc. Buy 7.71% 0%
ATRI Atrion Corporation Sell -4.01% -7.16%
NVRO Nevro Corp. Sell -3.5% 6.54%
ITGR Integer Holdings Corporation Sell -3.81% -1.87%
OFIX Orthofix Medical Inc. Sell -3.75% -0.08%
ALGN Align Technology, Inc. Sell -3.39% 7.36%
ALT Altimmune, Inc. Sell -3.74% -2.42%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.69% -0.99%
GKOS Glaukos Corporation Sell -4.12% 0%
The percentage of cash held in the portfolio is: 86.77%
New Assets Added
  • GKOS
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.45% 12.5%
SMMT Summit Therapeutics Inc. Buy 6.66% 0.52%
IBRX ImmunityBio, Inc. Buy 7.35% 0%
CDMO Avid Bioservices, Inc. Buy 7.35% 0%
CARA Cara Therapeutics, Inc. Buy 7.35% 0%
ATRI Atrion Corporation Sell -3.97% -6.33%
NVRO Nevro Corp. Sell -3.77% -0.88%
ITGR Integer Holdings Corporation Sell -3.91% -4.55%
OFIX Orthofix Medical Inc. Sell -3.76% -0.77%
ALGN Align Technology, Inc. Sell -3.65% 0%
ALT Altimmune, Inc. Sell -3.65% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.65% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • ALGN
  • ALT
  • EGRX
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.65% 0%
SMMT Summit Therapeutics Inc. Buy 6.65% 0%
ATRI Atrion Corporation Sell -3.75% 0%
NVRO Nevro Corp. Sell -3.75% 0%
ITGR Integer Holdings Corporation Sell -3.75% 0%
OFIX Orthofix Medical Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 101.71%
New Assets Added
  • ATRI
  • NVRO
  • ITGR
  • OFIX
  • PTCT
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-25 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All 31.35%
BKD Buy All -1.35%
FATE Buy All 31.42%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Sell -1.78% 45.39%
BKD Brookdale Senior Living Inc. Sell -3.09% 5.11%
FATE Fate Therapeutics, Inc. Sell -2.93% 10.05%
The percentage of cash held in the portfolio is: 107.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All -6.11%
Assets Rebalanced
None
2024-04-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.83% -1.53%
NUTX Nutex Health Inc. Sell -2.54% 22.54%
BKD Brookdale Senior Living Inc. Sell -3.27% 0.15%
FATE Fate Therapeutics, Inc. Sell -3.11% 5.1%
The percentage of cash held in the portfolio is: 98.08%
New Assets Added
None
Assets Removed
Asset Action Perf %
UTHR Buy All -3.27%
RVNC Sell All -9.76%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
RVNC Revance Therapeutics, Inc. Buy 9.54% -10.37%
OPK OPKO Health, Inc. Buy 10.79% -3.05%
UTHR United Therapeutics Corporation Sell -6.81% -3.51%
NUTX Nutex Health Inc. Sell -3.31% 0%
BKD Brookdale Senior Living Inc. Sell -3.31% 0%
FATE Fate Therapeutics, Inc. Sell -3.31% 0%
The percentage of cash held in the portfolio is: 96.42%
New Assets Added
  • NUTX
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
ANGO Sell All 20.18%
TNDM Sell All -2.07%
KIDS Sell All 9.67%
ACRS Sell All -7.94%
LXRX Sell All -15.83%
Assets Rebalanced
None
2024-04-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 12.12% 22.28%
TNDM Tandem Diabetes Care, Inc. Buy 9.79% -1.16%
KIDS OrthoPediatrics Corp. Buy 10.4% 4.94%
ACRS Aclaris Therapeutics, Inc. Buy 9.36% -5.56%
RVNC Revance Therapeutics, Inc. Buy 9.96% -4.67%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.01% -13.75%
OPK OPKO Health, Inc. Buy 11.51% 5.34%
UTHR United Therapeutics Corporation Sell -6.67% -3.19%
The percentage of cash held in the portfolio is: 34.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -1111.05%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 6.41% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 5.61% -5.1%
KIDS OrthoPediatrics Corp. Buy 5.44% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 5.72% -3.17%
RVNC Revance Therapeutics, Inc. Buy 5.71% -8.33%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.73% -7.92%
OPK OPKO Health, Inc. Buy 6.71% 3.05%
UTHR United Therapeutics Corporation Sell -3.83% 0.5%
NUTX Nutex Health Inc. Sell -3.73% 1.05%
The percentage of cash held in the portfolio is: 66.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -5.57%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 6% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 5.62% -4.11%
KIDS OrthoPediatrics Corp. Buy 5.71% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 5.86% 0%
VCYT Veracyte, Inc. Buy 5.84% -0.37%
RVNC Revance Therapeutics, Inc. Buy 5.94% -3.86%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.87% -5%
OPK OPKO Health, Inc. Buy 6.47% 0%
UTHR United Therapeutics Corporation Sell -3.8% 0.64%
NUTX Nutex Health Inc. Sell -3.74% 0%
The percentage of cash held in the portfolio is: 60.22%
New Assets Added
  • NUTX
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.92% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 5.77% 0.31%
KIDS OrthoPediatrics Corp. Buy 5.79% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 5.66% -1.59%
VCYT Veracyte, Inc. Buy 5.87% 2.03%
ATRI Atrion Corporation Buy 6.06% 0%
OFIX Orthofix Medical Inc. Buy 6.06% 0%
RVNC Revance Therapeutics, Inc. Buy 6.06% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.06% 0%
UTHR United Therapeutics Corporation Sell -3.75% 0%
The percentage of cash held in the portfolio is: 50.5%
New Assets Added
  • UTHR
  • ATRI
  • OFIX
  • RVNC
  • LXRX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.76% 0%
TNDM Tandem Diabetes Care, Inc. Buy 5.76% 0%
KIDS OrthoPediatrics Corp. Buy 5.76% 0%
ACRS Aclaris Therapeutics, Inc. Buy 5.76% 0%
VCYT Veracyte, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 71.18%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-03-22 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
FOLD Buy All 4.88%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Sell -4.64% 2.36%
The percentage of cash held in the portfolio is: 104.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -2.45%
BAX Sell All -2.7%
OMCL Sell All 0.5%
ADMA Sell All 3.27%
Assets Rebalanced
None
2024-03-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 7.55% -2.42%
OMCL Omnicell, Inc. Buy 7.69% -0.54%
ADMA ADMA Biologics, Inc. Buy 7.82% 1.14%
SMTI Sanara MedTech Inc. Sell -4.33% -1.22%
FOLD Amicus Therapeutics, Inc. Sell -4.58% 3.66%
The percentage of cash held in the portfolio is: 85.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAVA Buy All -10.84%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 7.48% -3.37%
OMCL Omnicell, Inc. Buy 7.65% -1.15%
ADMA ADMA Biologics, Inc. Buy 7.51% -2.94%
SMTI Sanara MedTech Inc. Sell -4.24% 1.03%
SAVA Cassava Sciences, Inc. Sell -4.59% -7.26%
FOLD Amicus Therapeutics, Inc. Sell -4.48% 5.78%
The percentage of cash held in the portfolio is: 90.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All -5.31%
BHVN Sell All 0.62%
RGNX Sell All 4.54%
RCM Sell All -7.19%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
QTRX Quanterix Corporation Buy 7.24% -5.42%
BHVN Biohaven Ltd. Buy 7.75% 1.21%
RGNX REGENXBIO Inc. Buy 7.95% 3.89%
BAX Baxter International Inc. Buy 7.47% -3.21%
OMCL Omnicell, Inc. Buy 7.69% -0.36%
ADMA ADMA Biologics, Inc. Buy 7.55% -2.12%
RCM R1 RCM Inc. Buy 7.03% -4.72%
SMTI Sanara MedTech Inc. Sell -4.3% -0.57%
SAVA Cassava Sciences, Inc. Sell -4.58% -7.31%
FOLD Amicus Therapeutics, Inc. Sell -4.43% 6.59%
The percentage of cash held in the portfolio is: 60.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Buy All 2.4%
THC Sell All 4.78%
RDNT Sell All 0.23%
NTRA Sell All 0.12%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.44% 6.1%
RDNT RadNet, Inc. Buy 7.87% -1.08%
NTRA Natera, Inc. Buy 7.81% -1.9%
QTRX Quanterix Corporation Buy 7.2% -6.02%
BHVN Biohaven Ltd. Buy 7.67% 0.05%
RGNX REGENXBIO Inc. Buy 7.84% 2.29%
BAX Baxter International Inc. Buy 7.55% -2.26%
OMCL Omnicell, Inc. Buy 7.67% -0.72%
ADMA ADMA Biologics, Inc. Buy 7.6% -1.63%
RCM R1 RCM Inc. Buy 7.11% -3.66%
ORGO Organogenesis Holdings Inc. Sell -3.44% 2.74%
SMTI Sanara MedTech Inc. Sell -4.22% 1.17%
SAVA Cassava Sciences, Inc. Sell -4.46% -4.28%
FOLD Amicus Therapeutics, Inc. Sell -4.46% 6.1%
The percentage of cash held in the portfolio is: 39.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.29% 6.46%
MRSN Mersana Therapeutics, Inc. Buy 7.52% -3.37%
RDNT RadNet, Inc. Buy 7.9% 1.53%
NTRA Natera, Inc. Buy 7.75% -0.5%
QTRX Quanterix Corporation Buy 7.03% -6.27%
BHVN Biohaven Ltd. Buy 7.94% 5.96%
RGNX REGENXBIO Inc. Buy 7.89% 5.2%
BAX Baxter International Inc. Buy 7.5% -0.72%
OMCL Omnicell, Inc. Buy 7.55% -0.11%
ADMA ADMA Biologics, Inc. Buy 7.73% 2.29%
RCM R1 RCM Inc. Buy 7.1% -1.69%
ORGO Organogenesis Holdings Inc. Sell -3.56% -2.74%
SMTI Sanara MedTech Inc. Sell -4.24% -1.39%
SAVA Cassava Sciences, Inc. Sell -4.35% -4.08%
FOLD Amicus Therapeutics, Inc. Sell -4.47% 3.91%
The percentage of cash held in the portfolio is: 32.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All -0.51%
RCKT Buy All 3%
XNCR Buy All -2.5%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.23% 6.01%
MRSN Mersana Therapeutics, Inc. Buy 7.37% -5.05%
RDNT RadNet, Inc. Buy 8.05% 3.77%
NTRA Natera, Inc. Buy 7.88% 1.57%
QTRX Quanterix Corporation Buy 7.14% -4.49%
BHVN Biohaven Ltd. Buy 7.76% 3.88%
RGNX REGENXBIO Inc. Buy 7.69% 2.9%
BAX Baxter International Inc. Buy 7.51% -0.23%
OMCL Omnicell, Inc. Buy 7.61% 1.04%
ADMA ADMA Biologics, Inc. Buy 7.65% 1.63%
RCM R1 RCM Inc. Buy 7.13% -1.06%
CUTR Cutera, Inc. Sell -3.39% -2.54%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.08% 6.79%
XNCR Xencor, Inc. Sell -3.31% -0.04%
ORGO Organogenesis Holdings Inc. Sell -3.48% -0.68%
SMTI Sanara MedTech Inc. Sell -4.18% -0.16%
SAVA Cassava Sciences, Inc. Sell -4.37% -4.89%
FOLD Amicus Therapeutics, Inc. Sell -4.44% 4.07%
The percentage of cash held in the portfolio is: 42.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
Assets Rebalanced
None
2024-03-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 7.98% 2.95%
MRSN Mersana Therapeutics, Inc. Buy 7.42% -4.21%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.61% -1.76%
RDNT RadNet, Inc. Buy 8.08% 4.24%
NTRA Natera, Inc. Buy 7.74% -0.15%
QTRX Quanterix Corporation Buy 7.01% -6.13%
BHVN Biohaven Ltd. Buy 7.33% -1.79%
RGNX REGENXBIO Inc. Buy 7.98% 6.98%
BAX Baxter International Inc. Buy 7.61% 1.14%
OMCL Omnicell, Inc. Buy 7.65% 1.76%
ADMA ADMA Biologics, Inc. Buy 7.6% 0.98%
RCM R1 RCM Inc. Buy 7.12% -1.06%
CUTR Cutera, Inc. Sell -3.38% -2.54%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.14% 4.93%
XNCR Xencor, Inc. Sell -3.35% -1.49%
ORGO Organogenesis Holdings Inc. Sell -3.52% -2.05%
SMTI Sanara MedTech Inc. Sell -4.13% 0.79%
SAVA Cassava Sciences, Inc. Sell -3.87% 7.06%
FOLD Amicus Therapeutics, Inc. Sell -4.57% 1.3%
The percentage of cash held in the portfolio is: 34.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
INO Buy All -33.33%
ACRS Sell All 3.2%
MD Sell All 2.02%
IONS Sell All -6.16%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings